Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes

Cardiovascular Research

Volumn 44, Issue 1, 1999, Pages 113-120

  Borst, Mathias M ^a   Szalai, Palma ^a   Herzog, Nicole ^a   Kübler, Wolfgang ^a   Strasser, Ruth H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adenosine; Adrenergic; Heart failure; Muscarinic agonists; Myocytes

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENYLATE CYCLASE; CARBACHOL; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; PHENYLISOPROPYLADENOSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONGESTIVE HEART FAILURE; DRUG EFFECT; HEART CONTRACTION; HEART VENTRICLE WALL; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM CHLORIDE; CARBACHOL; CELL SIZE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FORSKOLIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEART; HEART FAILURE, CONGESTIVE; ISOPROTERENOL; MALE; MICROSCOPY, POLARIZATION; MUSCARINIC AGONISTS; PHENYLISOPROPYLADENOSINE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; RECEPTORS, PURINERGIC P1; REGRESSION ANALYSIS;

EID: 0033214671     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00197-2     Document Type: Article

References (47)

1. 1-receptor down-regulation in heart failure. Circ Res. 59:1986;297-309.
2. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev. 43:1991;203-242.
3. 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol. 28:1996;1-10.
4. 1-adrenergic receptors in the failing human heart. Circulation. 87:1993;454-463.
5. Sethi R., Dhalla K.S., Beamish R.E., Dhalla N.S. Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. Am J Physiol. 272:1997;H884-H893.
6. iα-2 in human end-stage heart failure. Circ Res. 70:1992;688-696.
7. Ishikawa Y., Sorota S., Kiuchi K., et al. Downregulation of adenylylcyclase types V and VI. mRNA levels in pacing-induced heart failure in dogs. J Clin Invest. 93:1994;2224-2229.
8. Yamamoto J., Ohyanagi M., Morita M., Iwasaki T. β-Adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation. J Mol Cell Cardiol. 26:1994;617-626.
9. 1-adenosine receptor inhibition of adenylate cyclase in failing and non-failing human ventricular myocardium. Circulation. 83:1991;1343-4351.
10. i protein mediated muscarinic receptor adenylyl cyclase in chronic ischaemic heart failure in the rat. Cardiovasc Res. 27:1993;2065-2070.
11. Ping P., Anzai T., Gao M., Hammond H.K. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol. 273:1997;H707-H717.
12. Calderone A., Bouvier M., Li K., et al. Dysfunction of the β- and α-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res. 69:1991;332-343.
13. Calderone A., de Champlain J., Rouleau J.L. Adriamycin-induced changes to the myocardial beta-adrenergic system in the rabbit. J Mol Cell Cardiol. 23:1991;333-342.
14. Harding S.E., Jones S.M., Vescovo G., del Monte F., Poole-Wilson P.A. Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol. 223:1992;39-48.
15. Feldman A.M., Cates A.E., Veazey W.B., et al. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 82:1988;189-197.
16. i-proteins in heart failure. Lancet. 2:1988;936-937.
17. i during pacing-induced heart failure. Circulation. 94:1996;102-107.
18. Schrader J., Baumann G., Gerlach E. Adenosine as inhibitor of myocardial effects of catecholamines. Pflug Arch Eur J Physiol. 372:1977;29-35.
19. Dobson J.G. Mechanism of adenosine inhibition of catecholamine-induced responses in heart. Circ Res. 52:1983;151-160.
20. 2-muscarinic receptors increase in the canine pacing-overdrive model of heart failure. Can J Cardiol. 12:1996;71-76.
21. Le Guludec D., Cohen-Solal A., Delforge J., et al. Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy. An in vivo PET study. Circulation. 96:1997;3416-3422.
22. Dobson J.G., Ordway R.W., Fenton R.A. Endogenous adenosine inhibits catecholamine contractile responses in normoxic hearts. Am J Physiol. 251:1986;H455-H462.
23. Brown L.A., Humphrey S.M., Harding S.E. The anti-adrenergic effect of adenosine and its blockade by pertussis toxin: a comparative study in myocytes isolated from guinea-pig, rat, and failing human hearts. Br J Pharmacol. 101:1990;484-488.
24. Borst M.M., Schrader J. Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. Circ Res. 68:1991;797-806.
25. Albin R., Dowell R.T., Zak R., Rabinowitz M. Synthesis and degradation of mitochondrial components in hypertrophied rat heart. Biochem J. 136:1973;629-637.
26. Piper H.M., Volz A., Schwartz P. Adult ventricular rat heart muscle cells. Piper H.M., Spieckermann P. Adult heart muscle cells. 1985;36-60 Steinkopff, Darmstadt.
27. Harding S.E., Vescovo G., Kirby M., et al. Contractile responses of isolated adult rat and rabbit cardiac myocytes to isoproterenol and calcium. J Mol Cell Cardiol. 20:1988;635-647.
28. Sachs L. Angewandte Statistik. 1978;Springer-Verlag, Berlin.
29. Borst MM, Beuthien W, Schwencke C, et al. Desensitization of the pulmonary adenylyl cyclase system: A cause of airway hyperresponsiveness in congestive heart failure? J Am Coll Cardiol 1999;34:in press.
30. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 307:1982;205-211.
31. i alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 82:1990;1249-1265.
32. Ravens U., Davia K., Davies C.H., et al. Tachycardia-induced failure alters contractile properties of canine ventricular myocytes. Cardiovasc Res. 32:1996;613-621.
33. Vescovo G., Jones S.M., Harding S.E., Poole-Wilson P.A. Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure. J Mol Cell Cardiol. 21:1989;1047-1061.
34. 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart. Naunyn-Schmiedeberg's Arch Pharmacol. 353:1996;213-225.
35. Koglin J., Böhm M., von Scheidt W., Stäblein A., Erdmann E. Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in vivo. J Am Coll Cardiol. 23:1994;678-683.
36. Newton G.E., Parker A.B., Landzberg J.S., Colucci W.S., Parker J.D. Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle. J Clin Invest. 98:1996;2756-2763.
37. 1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res. 65:1989;1201-1211.
38. Newman W.H., Grossman S.J., Frankis M.B., Webb J.G. Increased myocardial adenosine release in heart failure. J Mol Cell Cardiol. 16:1984;577-580.
39. Funaya H., Kitakaze M., Node K., et al. Plasma adenosine levels increase in patients with chronic heart failure. Circulation. 95:1997;1363-1365.
40. Deussen A., Borst M., Kroll K., Schrader J. Formation of S-adenosylhomocysteine in the heart. II: A sensitive index for regional myocardial underperfusion. Circ Res. 63:1988;250-261.
41. Deussen A., Walter C., Borst M., Schrader J. Transmural gradient of adenosine in canine heart during functional hyperemia. Am J Physiol. 260:1991;H671-H680.
42. Böhm M., Deutsch H.J., Hartmann D., La Rosee K., Stäblein A. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol. 30:1997;992-996.
43. i proteins. Am J Physiol. 272:1997;H1672-H1679.
44. Mende U., Eschenhagen T., Geertz B., et al. Isoprenaline-induced increase in the 40/41 kDa pertussis toxin substrates and functional consequences on contractile response in rat heart. Naunyn-Schmiedeberg's Arch Pharmacol. 345:1992;44-50.
45. iα-proteins in patients with congestive heart failure. Eur J Clin Pharmacol. 51:1996;127-132.
46. 2 receptors of the adenylyl cyclase system. J Mol Cell Cardiol. 24:1992;535-548.
47. 2-muscarinic receptors in the human right atrium. Br J Pharmacol. 101:1990;363-369.